Journal
MOLECULAR MEDICINE
Volume 17, Issue 9-10, Pages 1045-1055Publisher
FEINSTEIN INST MED RES
DOI: 10.2119/molmed.2011.00129
Keywords
-
Funding
- Juvenile Diabetes Research Foundation
- Fight for Sight UK
- Sir Jules Thorn Trust
- Department of Employment & Leaning (DEL) (Northern Ireland)
- Medical Research Council UK
- Royal Society
- MRC [G0801962, G0600053] Funding Source: UKRI
- Fight for Sight [1883/84] Funding Source: researchfish
- Medical Research Council [G0600053, G0801962] Funding Source: researchfish
Ask authors/readers for more resources
Endothelicl progenitor cells (EPCs) promote angiogenesis, and clinical trials have shown such cell therapy to be feasible for treating ischemic disease. However, clinical outcomes have been contradictory owing to the diverse range of EPC types used. We recently characterized two EPC subtypes, and identified outgrowth endothelial cells as the only EPC type with true progenitor and endothelial characteristics. By contrast, myeloid angiogenic cells (MACs) were shown to be monocytic cells without endothelial characteristics despite being widely described as EPCs. In the current study we demonstrated that although MACs do not become endothelial cells or directly incorporate into a microvascular network, they can significantly induce endothelial tube formation in vitro and vascular repair in vivo. MAC-derived interleukin-8 (IL-8) was identified as a key paracrine factor, and blockade of IL-8 but not vascular endothelial growth factor (VEGF) prevented MAC-induced angiogenesis. Extracellular IL-8 transactivates VEGFR2 and induces phosphorylation of extracellular signal-regulated kinases. Further transcriptomic and immunophenotypic analysis indicates that MACs represent alternative activated M2 macrophages. Our findings demonstrate an unequivocal role for MACs in angiogenesis, which is linked to paracrine release of cytokines such as IL-8. We also show, for the first time, the true identity of these cells as alternative M2 macrophages with proangiogenic, antiinflammatory and pro-tissue-repair properties. (C) 2011 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: http://www.molmed.org doi: 10.2119/molmed.2011.00129
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available